-
Trastuzumab Deruxtecan in HER2+ Advanced Breast Cancer
New findings from the DESTINY-Breast12 study, published in Nature Medicine on September 13, 2024, highlight the efficacy of trastuzumab deruxtecan (T-DXd) in HER2-positive metastatic breast cancer (mBC), including patients with…
-
Patient Experience in Low-Risk DCIS: Insights from the COMET Trial
New insights from the COMET randomized clinical trial, published on December 12, 2024, in JAMA Oncology, offer important evidence on the patient experience in managing low-risk ductal carcinoma in situ…
-
New Hope for Drug-Resistant TB: MBLA Outperforms Xpert in Predicting Treatment Success
A new study published in the Journal of Infection reveals that the Molecular Bacterial Load Assay (MBLA) provides a faster and more accurate way to monitor treatment response in patients with pre-XDR/XDR-TB, compared to the widely used GeneXpert Ultra MTB/RIF test.
-
Dr. Andrea Mastrangelo Explores Unique CD8 T Cell Responses in HIV Controllers | hashtag CROI2025
New research led by Dr. Andrea Mastrangelo at Centre Hospitalier Universitaire Vaudois unveils a distinct transcriptomic signature in lymph node (LN) HIV-specific CD8 T cells of HIV controllers. Unlike chronic HIV-infected individuals (CHI), controllers exhibited an enriched population of stem-like CD8 T cells marked by TCF7, IL7R, and BACH2, which may contribute to proliferative potential…
-
Investigating the Evolution of Global and Endemic Clade II MPXV | Dr. Rebecca P Sumner at hashtag CROI2025
New research from Dr. Rebecca P Sumner at the University of Surrey uncovers key biological differences between the global MPXV lineage B and its ancestral lineage A, which remains endemic in Africa.
-
SGBCC 2025 | Dr. Cynthia Villarreal-Garza: Monitoring and Management of Long-term Toxicities in Young Breast Cancer Patients
The impact of long-term toxicity management on patient quality of life is increasingly being recognized in breast cancer treatment. At the recently held 19th St. Gallen Breast Cancer Conference (SGBCC 2025), Dr. Cynthia Villarreal-Garza, Director of Clinic Oncology at the Breast Cancer Center, TecSalud,delivered a presentation titled “Ensuring Long-term Healthy Survival of Breast Cancer Patients.”…
-
JOH | A New Prognostic Indicator for Post-TIPS Survival Risk – The Freiburg Index
Recently, an important study by the German Liver Cirrhosis Research Group (DGVS) introduced the Freiburg Index (FIPS), which integrates age, serum creatinine, bilirubin, and albumin levels to effectively identify high-risk…
-
POST-ASCO GI丨2025 From Following to Leading Dr. Yanhong Deng on China’s Breakthroughs in Colorectal Cancer Molecular Classification and a New Paradigm
In this exclusive interview, Professor Deng reflects on the evolution of the POST-ASCO GI meeting, now in its 11th year, as a bridge between global advancements and domestic practice. She…
Connecting Medical Expertise through Media